PDXK
MOLECULAR TARGETpyridoxal kinase
PDXK (pyridoxal kinase) is targeted by 6 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting PDXK
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | bi 2536 | 4.01 | 54 |
| 2 | volasertib | 2.94 | 18 |
| 3 | tg100 115 | 2.08 | 7 |
| 4 | lucitanib | 1.95 | 6 |
| 5 | fgfr inhibitor debio 1347 | 1.79 | 5 |
| 6 | Pyridoxine | 0.69 | 1 |
About PDXK as a Drug Target
PDXK (pyridoxal kinase) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 6 compounds with documented PDXK interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
PDXK inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.